Skip to main content
SpringerLink
Log in

Atezolizumab

Cholangitis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Azami T, et al. Anti programmed death-ligand 1 antibody-related cholangitis without bile duct dilation or stenosis. Clinical Journal of Gastroenterology 15: 818-821, No. 4, 2022. Available from: URL: http://doi.org/10.1007/s12328-022-01651-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atezolizumab. Reactions Weekly 1921, 50 (2022). https://doi.org/10.1007/s40278-022-22044-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-22044-z

Search

Navigation